Company news

Anika Therapeutics Inc. news in 2020

Anika Therapeutics Inc.'s news releases, calls and decks from 2020, newest first.

View company

Anika Reports Third-Quarter 2020 Financial Results

November 3, 2020

Anika Announces FDA 510(k) Clearance for its WristMotion® Total Arthroplasty System for the Replacement of Painful Wrist Joints

October 20, 2020

Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors

September 7, 2020

Anika Appoints Michael Levitz as Chief Financial Officer

August 4, 2020

Anika Reports Second Quarter 2020 Financial Results

July 29, 2020

Anika To Launch Six FDA-Cleared Sports Medicine and Extremities Products in Third Quarter of 2020

July 19, 2020

Anika Announces Planned CFO Transition

June 1, 2020

Anika Reports First Quarter 2020 Financial Results

May 6, 2020

Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer

April 26, 2020

Anika to Issue First Quarter 2020 Financial Results and Business Highlights on Thursday, May 7

April 22, 2020

Anika Takes Actions to Strengthen Liquidity in Light of COVID-19

April 7, 2020

Anika Appoints David Colleran as General Counsel

March 3, 2020

Anika Reports Fourth Quarter and Full Year 2019 Financial Results

February 19, 2020

Anika Therapeutics Names Board Member Dr. Cheryl Blanchard as Interim CEO

February 11, 2020

CORRECTING and REPLACING Anika to Issue Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights on Thursday, February 20

February 5, 2020

Anika Therapeutics Closes Acquisition of Arthrosurface

February 2, 2020

Anika Therapeutics Mourns the Sudden Passing of Joseph Darling, President and Chief Executive Officer

January 28, 2020

Anika Therapeutics Closes Acquisition of Parcus Medical

January 23, 2020

Anika Therapeutics to Acquire Parcus Medical and Arthrosurface

January 5, 2020

Decks in 2020